SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

Press Release: Gilead Sciences Announces Fourth -8-

· 02/04/2021 16:01
Europe 207 141 735 370 Biktarvy -- Other International 115 72 429 143 ------ ------ --------- --------- 2,071 1,570 7,259 4,738 ------ ------ --------- --------- Descovy -- U.S. 402 343 1,526 1,078 Descovy -- Europe 41 55 197 255 Descovy -- Other International 35 39 138 167 ------ ------ --------- --------- 478 437 1,861 1,500 ------ ------ --------- --------- Genvoya -- U.S. 678 762 2,605 2,984 Genvoya -- Europe 114 142 490 664 Genvoya -- Other International 60 54 243 283 ------ ------ --------- --------- 852 958 3,338 3,931 ------ ------ --------- --------- Odefsey -- U.S. 321 315 1,172 1,180 Odefsey -- Europe 109 110 450 438 Odefsey -- Other International 14 10 50 37 ------ ------ --------- --------- 444 435 1,672 1,655 ------ ------ --------- --------- Revenue share -- Symtuza(1) -- U.S. 87 84 331 249 Revenue share -- Symtuza(1) -- Europe 37 41 149 130 Revenue share -- Symtuza(1) -- Other International 2 -- 8 -- ------ ------ --------- --------- 126 125 488 379 ------ ------ --------- --------- Total Descovy (FTC/TAF) Based Products -- U.S. 3,237 2,861 11,729 9,716 Total Descovy (FTC/TAF) Based Products -- Europe 508 489 2,021 1,857 Total Descovy (FTC/TAF) Based Products -- Other International 226 175 868 630 ------ ------ --------- --------- 3,971 3,525 14,618 12,203 ------ ------ --------- --------- Truvada (FTC/TDF) Based Products Atripla -- U.S. 32 114 307 501 Atripla -- Europe 4 8 21 60 Atripla -- Other International 2 6 21 39 ------ ------ --------- --------- 38 128 349 600 ------ ------ --------- --------- Complera / Eviplera -- U.S. 12 34 89 160 Complera / Eviplera -- Europe 35 35 159 214 Complera / Eviplera -- Other International 4 6 21 32 ------ ------ --------- --------- 51 75 269 406 ------ ------ --------- --------- Stribild -- U.S. 25 60 125 268 Stribild -- Europe 12 15 54 75 Stribild -- Other International 5 (4) 17 26 ------ ------ --------- --------- 42 71 196 369 ------ ------ --------- --------- Truvada -- U.S. 131 744 1,376 2,640 Truvada -- Europe 7 13 27 101 Truvada -- Other International 8 11 45 72 ------ ------ --------- --------- 146 768 1,448 2,813 ------ ------ --------- --------- Total Truvada (FTC/TDF) Based Products -- U.S. 200 952 1,897 3,569 Total Truvada (FTC/TDF) Based Products -- Europe 58 71 261 450 Total Truvada (FTC/TDF) Based Products -- Other International 19 19 104 169 ------ ------ --------- --------- 277 1,042 2,262 4,188 ------ ------ --------- --------- GILEAD SCIENCES, INC. PRODUCT SALES SUMMARY - (Continued) (unaudited) Three Months Ended Twelve Months Ended December 31, December 31, ------------------- --------------------- 2020 2019 2020 2019 ------------------- --------- -------- -------- ----------- Other HIV(2) -- U.S. 1 7 25 30 Other HIV(2) -- Europe 1 2 5 5 Other HIV(2) -- Other International 7 1 28 12 -------- -------- -------- --------- 9 10 58 47 -------- -------- -------- --------- Total HIV -- U.S. 3,438 3,820 13,651 13,315 Total HIV -- Europe 567 562 2,287 2,312 Total HIV -- Other International 252 195 1,000 811 -------- -------- -------- --------- 4,257 4,577 16,938 16,438 -------- -------- -------- --------- HCV Products ------------------- Ledipasvir / Sofosbuvir(3) -- U.S. (21) 55 92 312 Ledipasvir / Sofosbuvir(3) -- Europe 3 8 29 71 Ledipasvir / Sofosbuvir(3) -- Other International 27 38 151 260 -------- -------- -------- --------- 9 101 272 643 -------- -------- -------- --------- Sofosbuvir / Velpatasvir(4) -- U.S. 218 240 864 971 Sofosbuvir / Velpatasvir(4) -- Europe 84 125 337 553 Sofosbuvir / Velpatasvir(4) -- Other International 68 100 398 441 -------- -------- -------- --------- 370 465 1,599 1,965 -------- -------- -------- --------- Other HCV(5) -- U.S. 32 42 132 182 Other HCV(5) -- Europe 11 18 48 118 Other HCV(5) -- Other International 1 4 13 28 -------- -------- -------- --------- 44 64 193 328 -------- -------- -------- --------- Total HCV -- U.S. 229 337 1,088 1,465 Total HCV -- Europe 98 151 414 742 Total HCV -- Other International 96 142 562 729 -------- -------- -------- --------- 423 630 2,064 2,936 -------- -------- -------- --------- Veklury ------------------- Veklury -- U.S. 1,241 -- 2,026 -- Veklury -- Europe 547 -- 607 -- Veklury -- Other International 150 -- 178 -- -------- -------- -------- --------- 1,938 -- 2,811 -- -------- -------- -------- --------- Cell Therapy Products ------------------- Tecartus -- U.S. 29 -- 34 -- Tecartus -- Europe 5 -- 10 -- Tecartus -- Other International -- -- -- -- -------- -------- -------- --------- 34 -- 44 -- -------- -------- -------- --------- Yescarta -- U.S. 79 98 362 373 Yescarta -- Europe 47 24 191 83 Yescarta -- Other International 3 -- 10 -- -------- -------- -------- --------- 129 122 563 456 -------- -------- -------- --------- Total Cell Therapy -- U.S. 108 98 396 373 Total Cell Therapy -- Europe 52 24 201 83 Total Cell Therapy -- Other International 3 -- 10 -- -------- -------- -------- --------- 163 122 607 456 -------- -------- -------- --------- Trodelvy - U.S.(7) 49 -- 49 --

(MORE TO FOLLOW) Dow Jones Newswires

February 04, 2021 16:01 ET (21:01 GMT)